Next Sequence
Venture capitalInvestment thesis
Next Sequence backs startups working at the intersection of artificial intelligence and biology, describing this focus as 'AI and Biology'. The firm targets companies it believes are shaping the future of humanity, aiming to invest across ventures that combine computational and life-science approaches. It has set a target of $125 million in invested capital by 2030 and currently supports a small portfolio of early companies, working alongside a team of operating partners and associates.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 1 of 2 portfolio companiesMarketplaces Γ1
Investments Β· 2 tracked
founders shown can be your intro pathFrequently asked questions
- What sectors does Next Sequence focus on?
- Next Sequence focuses on AI & Machine Learning, Biotech.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital is a venture and growth investment firm that backs technology companies, including a dedicated Resilience Tech practice focused on energy, industrial and infrastructure systems.
Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.